Jeffrey Stevens, the CEO and co-founder of Psyched Wellness PSYCF, has bought 321,000 shares of the company in the open market at CA$0.125 per share for a total cost of of CA$40,125 (around $31,750).
“Our stock price has increased in the last quarter alone. In addition to our market growth, we have experienced a number of recent successes that have strengthened our position and are excited to be approved to launch our flagship product, Calm, in the U.S.," Stevens said.
The psychedelics exec is speaking later Tuesday at the inaugural Benzinga Psychedelics Capital Conference.
"Our stock price doesn't reflect this growth yet, but it will. We have been working diligently to position and grow our business, and I believe that we are on track to deliver sustainable, long-term shareholder value.”
PSYCF Price Action: Psyched Wellness shares were trading 2.22% higher at $0.092 late Tuesday morning.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!